Cost-Effectiveness of Golimumab in Ankylosing Spondylitis from the UK Payer Perspective
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-6584
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cost-Effectiveness of Golimumab in Ankylosing Spondylitis from the UK Payer Perspective ; volume:4 ; number:2 ; day:27 ; month:9 ; year:2017 ; pages:427-443 ; date:12.2017
Rheumatology and therapy ; 4, Heft 2 (27.9.2017), 427-443, 12.2017
- Classification
-
Medizin, Gesundheit
- Creator
-
Borse, Rebekah H.
- Contributor
-
Brown, Chloe
Muszbek, Noemi
Chaudhary, Mohammad Ashraf
Kachroo, Sumesh
SpringerLink (Online service)
- DOI
-
10.1007/s40744-017-0083-1
- URN
-
urn:nbn:de:1111-201801234469
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:04 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Borse, Rebekah H.
- Brown, Chloe
- Muszbek, Noemi
- Chaudhary, Mohammad Ashraf
- Kachroo, Sumesh
- SpringerLink (Online service)
Other Objects (12)
Andersson lesion in ankylosing spondylitis
Surgical treatment of ankylosing spondylitis deformity
Secukinumab: A Review in Ankylosing Spondylitis
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
ANKHvariants associated with ankylosing spondylitis: gender differences
Atherosclerosis in Egyptian patients with ankylosing spondylitis
Association between ankylosing spondylitis and m6A methylation
Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis
Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
Correction to: Secukinumab: A Review in Ankylosing Spondylitis
Development of early diagnostic systems for ankylosing spondylitis
Autoimmune inner ear disease associated with ankylosing spondylitis
Andersson lesion in ankylosing spondylitis
Surgical treatment of ankylosing spondylitis deformity
Secukinumab: A Review in Ankylosing Spondylitis
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
ANKHvariants associated with ankylosing spondylitis: gender differences
Atherosclerosis in Egyptian patients with ankylosing spondylitis
Association between ankylosing spondylitis and m6A methylation
Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis
Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
Correction to: Secukinumab: A Review in Ankylosing Spondylitis
Development of early diagnostic systems for ankylosing spondylitis
Autoimmune inner ear disease associated with ankylosing spondylitis
Andersson lesion in ankylosing spondylitis
Surgical treatment of ankylosing spondylitis deformity
Secukinumab: A Review in Ankylosing Spondylitis
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
ANKHvariants associated with ankylosing spondylitis: gender differences
Atherosclerosis in Egyptian patients with ankylosing spondylitis
Association between ankylosing spondylitis and m6A methylation
Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis
Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
Correction to: Secukinumab: A Review in Ankylosing Spondylitis
Development of early diagnostic systems for ankylosing spondylitis